YELLOW SPRINGS, Ohio — YSI Incorporated, a Xylem Company, is excited to announce that their new 2900C Biochemistry Analyzer has been cleared by the U.S. Food and Drug Administration (FDA) as a medical device for glucose measurement in blood. 

For over 50 years, if a laboratory wanted to accurately know the amount of glucose in whole blood and plasma, then YSI was the go-to supplier. YSI's Biochemistry Analyzers have been and continue to be the gold standard in the industry. 

"The recent clearance by the FDA once again demonstrates YSI's commitment to offering the most innovative workflow solutions to the marketplace," states Ben Sutter, product manager. 

The new 2900C Biochemistry Analyzer complements the family of analyzers utilizing YSI's proprietary immobilized enzyme electrodes. Other products in this portfolio can also routinely test for Lactate, Glutamine, Glutamate, Ammonium, Potassium, Xylose, Ethanol, Methanol, Sucrose, Galactose, Lactose, Choline, Glycerol, and Hydrogen Peroxide. 

Key Features of the YSI 2900C: 
•   Intuitive touch screen interface
•   Platform versatility to add or remove modules for testing flexibility
•   Ability to measure up to 6 chemistries on one sample
•   Simple maintenance routines
•   Analysis times of 60 seconds or less

Although the innovation provides deep insights across multiple markets, the recent FDA clearance for the 2900C is specifically targeted at glucose device manufacturers and clinical diabetes research facilities. 

About Xylem Lab Solutions: Xylem Lab Solutions provides industry-leading laboratory equipment for water quality, food and beverage, pharmaceutical, and environmental applications. Founded in 1948, YSI is a market leader in electrochemistry probes and Life Science analyzers. ysi.com/lab-solutions.